1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Hepatitis B Vaccine Market
2.2. Global Hepatitis B Vaccine Market, By Composition, 2023 (US$ Million)
2.3. Global Hepatitis B Vaccine Market, By End Users Age, 2023 (US$ Million)
2.4. Global Hepatitis B Vaccine Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Hepatitis B Vaccine Market: Competitive Analysis
3.1. Market Positioning of Key Hepatitis B Vaccine Market Vendors
3.2. Strategies Adopted by Hepatitis B Vaccine Market Vendors
3.3. Key Industry Strategies
4. Hepatitis B Vaccine Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Hepatitis B Vaccine Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Combination Vaccines
5.3.2. Mono Vaccines

6. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Adult Hepatitis B vaccines
6.3.2. Paediatric Hepatitis B vaccines


7. North America Hepatitis B Vaccine Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
7.3. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
7.4.Hepatitis B Vaccine Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
7.4.1.1.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
7.4.1.2.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
7.4.1.3.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)

8. UK and European Union Hepatitis B Vaccine Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
8.3. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
8.4.Hepatitis B Vaccine Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
8.4.1.1.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
8.4.1.2.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
8.4.1.3.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
8.4.1.4.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
8.4.1.5.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
8.4.1.6.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)

9. Asia Pacific Hepatitis B Vaccine Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
9.3. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
9.4.Hepatitis B Vaccine Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
9.4.1.1.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
9.4.1.2.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
9.4.1.3.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
9.4.1.4.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
9.4.1.5.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
9.4.1.6.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)

10. Latin America Hepatitis B Vaccine Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
10.3. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
10.4.Hepatitis B Vaccine Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
10.4.1.1.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
10.4.1.2.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
10.4.1.3.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)

11. Middle East and Africa Hepatitis B Vaccine Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
11.3. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
11.4.Hepatitis B Vaccine Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
11.4.1.1.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
11.4.1.2.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Hepatitis B Vaccine Market: By Composition, 2022-2032, USD (Million)
11.4.1.3.2. Hepatitis B Vaccine Market: By End Users Age, 2022-2032, USD (Million)

12. Company Profile
12.1. Beijing Minhai Biotechnology
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. CSL Limited
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Dynavax Technologies
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Emergent Biosolutions
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. GlaxoSmithKline Biologicals
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Merck & Co, Inc.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Novartis AG
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Pfizer Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Sanofi Pasteur
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Serum Institute of India
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Sinovac Biotech
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives